Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples

Bladder cancer (BC) is the ninth most common cancer worldwide, but molecular changes are still under study. During tumor progression, Epithelial cadherin (E-cadherin) expression is altered and β-catenin may be translocated to the nucleus, where it acts as co-transcription factor of tumor invasion as...

ver descrição completa

Detalhes bibliográficos

Principais autores:	María Victoria Mencucci, Lara Lapyckyj, Marina Rosso, María José Besso, Denise Belgorosky, Mariana Isola, Silvia Vanzulli, Catalina Lodillinsky, Ana María Eiján, Juan Carlos Tejerizo, Matías Ignacio Gonzalez, María Ercilia Zubieta, Mónica Hebe Vazquez-Levin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-03-01
coleção:	Frontiers in Oncology
Assuntos:	bladder cancer epithelial cadherin beta-catenin Ephrin-B1 biomarker
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fonc.2020.00283/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!